Aarman Sohaili

Mr. Aarman Sohaili


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
ASAarman Sohaili
Aarman Sohaili
JAJudith Asin
Judith Asin
PTPierre Thomas
Pierre Thomas
Antimicrobial resistance (AMR) jeopardizes the effectiveness of essential antimicrobial agents in treating infectious diseases. Accelerated by human activities, AMR is prevalent in Sub-Saharan Africa, including Kenya, due to indiscriminate antibiotic use and limited diagnostics. This study aimed to assess Kenya’s AMR efforts through a situational analysis of policy efficacy, interventions, and implementation, culminating in recommendations for strengthening mitigation. Employing two methodologies, this study evaluated Kenya’s AMR endeavors. A systematic scoping review summarized AMR dynamic, and an expert validated the findings, providing an on-the-ground perspective. Antibiotic resistance is driven by factors including widespread misuse in human medicine due to irrational practices, consumer demand, and substandard antibiotics. Heavy antibiotic use in the agricultural sector leads to contamination of the food chain. The National Action Plan (NAP) reflects a One Health approach, yet decentralized healthcare and funding gaps hinder its execution. Although AMR surveillance includes multiple facets, diagnostic deficiencies persist. Expert insights recognize proactive NAP but underscore implementation obstacles. Kenya grapples with escalating resistance, but commendable policy efforts exist. However, fragmented implementations and complexities persist. Addressing this global threat demands investment in healthcare infrastructure, diagnostics, international partnerships, and sustainable strategies.

18 June 2024 in Viruses
Verified
Journal Article
Open access
PDF file
JMJobran M Moshi
Jobran M Moshi
ASAarman Sohaili
Aarman Sohaili
HMHassan N. Moafa
Hassan N. Moafa
AHAhlam Mohammed S. Hakami
Ahlam Mohammed S. Hakami
MMMohsen M. Mashi
Mohsen M. Mashi
PTPierre Thomas
Pierre Thomas
Cervical cancer, along with other sexual and reproductive health and rights (SRHR) conditions, poses a significant burden in the Kingdom of Saudi Arabia (KSA). Despite the availability of effective preventive methods such as vaccinations, particularly against the Human Papillomavirus (HPV), awareness about such preventive methods and HPV vaccination remains alarmingly low in the KSA, even with governmental effort and support. While many women are aware of the risks, the uptake of the HPV vaccine remains below 10% (7.6%) at the country level. This highlights the urgent need for Knowledge, Attitude, and Practice (KAP) at the community level to raise awareness, dispel misconceptions, and empower women to embrace vaccinations. Additionally, there is a need to revitalize the cancer registry system to better track and monitor cervical cancer cases. This short communication aims to map these barriers while identifying opportunities for impactful research. Drawing from the scientific literature, government reports, and expert insights, we highlight the challenges surrounding the tackling of HPV. By exploring diverse sources of knowledge, this paper not only highlights current obstacles but also proposes actionable solutions for future interventions.

20 November 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAarman Sohaili
Aarman Sohaili
ZAZoïe Alexiou
Zoïe Alexiou
FMFelix Mogaka
Felix Mogaka
VOVictor Ocholla Omollo
Victor Ocholla Omollo
SMServaas A. Morré
Servaas A. Morré
PTPierre P. M. Thomas
Pierre P. M. Thomas
The epidemiology of Chlamydia trachomatis (CT) in Kenya is not well understood. We conducted a systematic review and meta-analysis of CT prevalence using PubMed, Embase, and Kenyan databases (Jan 2000–June 2024). Included studies had laboratory-confirmed CT and were peer-reviewed. Populations were categorized by sex/gender and STI vulnerability. A random-effects model was used to account for heterogeneity. Of 198 records, 51 studies (32,559 participants) were included. CT prevalence was reported for 18 studies on males, 36 on females, and four on the general population. Pooled prevalence was 5.8% (95% CI 4.6–7.4) with high heterogeneity. The highest prevalence was among general population females > 25 years (14.8%), while at risk males > 25 had the lowest (0.1%). Studies spanned 13 regions, with Nairobi, Kisumu, and Mombasa most represented. CT prevalence in Kenya aligns with WHO estimates for Africa. High prevalence among general population women > 25 challenges traditional STI risk assumptions. Importantly, the association between HIV and CT was not uniform across populations, suggesting that relying solely on HIV-focused platforms may overlook groups with a substantial CT burden. Addressing diagnostic gaps, urban–rural disparities, and links with HIV care is critical. Trial registration CRD42024567235